Sanara MedTech

Sanara MedTech

SMTI· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock -29.7% in FY2025

Seth D. Yon is the CEO of Sanara MedTech and was paid $2.3M in FY2025 (Dec).

Pay$100 in the stock at the end of FY24 → $70
CEO pay is from each Sanara MedTech proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives5

See all
  1. 1Seth D. YonFY2025
  2. 2Suresh V. MuppallaFY2025
  3. 3Elizabeth B. TaylorFY2025
  4. 4Ronald T. NixonFY2025
  5. 5Jacob A. WaldropFY2024

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Sanara MedTech paid its 4 named executives $4.2M in total in FY2025 (Dec). CEO Seth D. Yon was paid $2.3M of that.

Name
Seth D. YonPresident and Chief Executive OfficerNot disclosedNot disclosed
Suresh V. MuppallaFormer President and Chief Executive Officer of Tissue Health Plus, LLCNot disclosedNot disclosed
Elizabeth B. TaylorChief Financial OfficerNot disclosedNot disclosed
Ronald T. NixonFormer Chief Executive OfficerNot disclosed
Jacob A. WaldropChief Operating OfficerNot disclosedNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers

No disclosed peer group

No proxy on file names a pay peer group for Sanara MedTech. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Activity

Filings6

See all
Proxy statementDEF 14AApr 17, 2026FY2025
Annual report10-KMar 24, 2026FY2025
Proxy statementDEF 14AApr 21, 2025FY2024
Annual report10-KMar 25, 2025FY2024
Proxy statementDEF 14AApr 15, 2024FY2023
Annual report10-KMar 25, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data